The EMA has announced, following the first-ever public hearing on valproate, that it would hold a second public hearing regarding the use of quinolone and fluoroquinolone antibiotics.
Ook interessant voor je
The EMA has announced, following the first-ever public hearing on valproate, that it would hold a second public hearing regarding the use of quinolone and fluoroquinolone antibiotics.
Pharmamarketeer richt zich op marketingprofessionals van farmaceuten en andere medisch-gerelateerde organisaties in Nederland en België.
Copyright 2023 © Uitgave van MedHealth Communications BV | Privacy disclaimer
Reageer